Dr. Reddy’s debuts generic RevlimidDr. Reddy’s is eligible for first to market, 180 days of generic drug exclusivity for lenalidomide capsules in 2.5-mg and 20-mg strengths. Xiromed launches generic FaslodexGeneric Faslodex is used to treat advanced-stage, hormone receptor-positive, HER2-negative breast cancer. Alembic intros generic Epiduo Forte Epiduo Forte is indicated for the topical treatment of acne vulgaris in adults and pediatric patients aged 12 years old and older. Dr. Reddy’s, Aurigene Pharmaceutical Services to explore drugs for neglected tropical diseases The parties will work toward ensuring access to drugs at affordable prices to patients in need. Cipla receives FDA confirmation for generic Revlimid Lenalidomide is an immunomodulatory drug indicated for several hematological malignancies in adults. Amneal appoints EVP, chief commercial officer of specialty Amneal has appointed Gustavo Pesquin as executive vice president, chief commercial officer of specialty, effective Sept. 6. Fresenius Kabi’s biosimilar Stimufend obtains FDA OK Stimufend is indicated for the treatment of cancer patients undergoing chemotherapy to reduce the incidence of infection as manifested by febrile neutropenia. Lannett completes clinical trial subject dosing of biosimilar insulin glargine Lannett anticipates launching biosimilar insulin glargine in the first half of 2024. Mayne Pharma welcomes board member, announces deputy chair’s retirement David Petrie is joining the board and Ian Scholes, deputy chair, will retire from the board at the end of September. Lupin obtains tentative nod, approval for 2 generics Generic Sprycel is indicated for adults with a certain type of chronic myeloid leukemia and generic Pristiq is used to treat depression. First Previous 85 86 87 88 89 Next Last
